1. PI3K/Akt/mTOR Anti-infection Apoptosis Autophagy
  2. mTOR Influenza Virus Apoptosis Autophagy
  3. Aloe emodin

Aloe emodin  (Synonyms: Rhabarberone; 3-Hydroxymethylchrysazine)

製品番号: HY-N0189 純度: 98.32%
COA 取扱説明書 Technical Support

Aloe emodin (Rhabarberone) is a natural hydroxyanthraquinone with antitumor activities. aloe-emodin can bind with mTORC2 and inhibit its kinase activity. Aloe emodin exerts antiproliferation effects and induces cellular apoptosis. Aloe emodin also exhibits antiviral activity that against influenza A virus.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 481-72-1

容量 価格(税別) 在庫状況 数量
>無料サンプル (0.1 - 0.2 mg)   今すぐ申し込む  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 107 在庫あり
Solution
10 mM * 1 mL in DMSO USD 107 在庫あり
Solid
100 mg $98 在庫あり
500 mg $246 在庫あり
1 g   お問い合わせ  
5 g   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 3 publication(s) in Google Scholar

Other Forms of Aloe emodin:

Top Publications Citing Use of Products

    Aloe emodin purchased from MedChemExpress. Usage Cited in: Heliyon. 2024 Jul 22;10(15):e34932.  [Abstract]

    Changes in body weights of mice were monitored following treatment with different doses of AE (Aloe emodin) in a mouse model of colitis induced by DSS.

    Aloe emodin purchased from MedChemExpress. Usage Cited in: Heliyon. 2024 Jul 22;10(15):e34932.  [Abstract]

    Aloe emodin (5,10,50 mg/mL). H&E staining of colon tissue sections. Histological evaluation of H&E-stained colon tissue sections to assess tissue damage and inflammation.

    Aloe emodin purchased from MedChemExpress. Usage Cited in: Heliyon. 2024 Jul 22;10(15):e34932.  [Abstract]

    Aloe emodin (5, 10, 50 mg/kg). Serum levels of inflammatory cytokines IL-17 and TNF-α were detected by ELISA.

    mTOR アイソフォーム固有の製品をすべて表示:

    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    Aloe emodin (Rhabarberone) is a natural hydroxyanthraquinone with antitumor activities. aloe-emodin can bind with mTORC2 and inhibit its kinase activity. Aloe emodin exerts antiproliferation effects and induces cellular apoptosis[1]. Aloe emodin also exhibits antiviral activity that against influenza A virus[2].

    IC50 & Target[1]

    mTORC2

     

    Cellular Effect
    Cell Line Type Value Description References
    A2780 IC50
    26 3
    Compound: 2
    Cytotoxicity against human A2780 cells
    Cytotoxicity against human A2780 cells
    [PMID: 24326280]
    B16-F10 IC50
    3.12 3
    Compound: 1
    Anticancer activity against mouse B16-F10 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Anticancer activity against mouse B16-F10 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    A2780 IC50
    26 3
    Compound: 2
    Cytotoxicity against human A2780 cells
    Cytotoxicity against human A2780 cells
    [PMID: 24326280]
    B16-F10 IC50
    3.12 3
    Compound: 1
    Anticancer activity against mouse B16-F10 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Anticancer activity against mouse B16-F10 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    HCT-116 IC50
    8.7 3
    Compound: 4
    Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay
    Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay
    [PMID: 17949858]
    B16-F10 IC50
    3.12 3
    Compound: 1
    Anticancer activity against mouse B16-F10 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Anticancer activity against mouse B16-F10 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    HCT-116 IC50
    8.7 3
    Compound: 4
    Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay
    Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay
    [PMID: 17949858]
    HEK293 IC50
    1 3
    Compound: 1
    Cytotoxicity against human HEK293 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Cytotoxicity against human HEK293 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    HEK293 IC50
    1 3
    Compound: 1
    Cytotoxicity against human HEK293 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Cytotoxicity against human HEK293 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    HepG2 IC50
    10 3
    Compound: 4
    Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay
    Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay
    [PMID: 17949858]
    HCT-116 IC50
    8.7 3
    Compound: 4
    Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay
    Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay
    [PMID: 17949858]
    HepG2 IC50
    6.13 3
    Compound: 1
    Anticancer activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Anticancer activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    HepG2 IC50
    6.13 3
    Compound: 1
    Anticancer activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Anticancer activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    Huh-7 CC50
    > 50 3
    Compound: 25
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    [PMID: 22445328]
    HEK293 IC50
    1 3
    Compound: 1
    Cytotoxicity against human HEK293 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Cytotoxicity against human HEK293 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    HepG2 IC50
    10 3
    Compound: 4
    Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay
    Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay
    [PMID: 17949858]
    Huh-7 EC50
    20.8 3
    Compound: 25
    Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
    Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
    [PMID: 22445328]
    HepG2 IC50
    10 3
    Compound: 4
    Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay
    Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay
    [PMID: 17949858]
    HepG2 2.2.15 IC50
    300 6
    Compound: 54
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production
    [PMID: 24549242]
    MCF7 IC50
    > 20 3
    Compound: AE
    Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay
    Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay
    [PMID: 24900344]
    HepG2 IC50
    6.13 3
    Compound: 1
    Anticancer activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Anticancer activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    Huh-7 CC50
    >50 3
    Compound: 25
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    [PMID: 22445328]
    HepG2 2.2.15 IC50
    300 6
    Compound: 54
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production
    [PMID: 24549242]
    Huh-7 EC50
    20.8 3
    Compound: 25
    Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
    Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
    [PMID: 22445328]
    MCF7 IC50
    4.14 3
    Compound: 1
    Anticancer activity against human MCF-7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Anticancer activity against human MCF-7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    HepG2 2.2.15 IC50
    300 6
    Compound: 54
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV e antigen secretion
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV e antigen secretion
    [PMID: 24549242]
    MCF7 IC50
    4.14 3
    Compound: 1
    Anticancer activity against human MCF-7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Anticancer activity against human MCF-7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    MDA-MB-231 IC50
    12.24 3
    Compound: 1
    Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    HepG2 2.2.15 IC50
    300 6
    Compound: 54
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion
    [PMID: 24549242]
    MCF7 IC50
    >20 3
    Compound: AE
    Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay
    Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay
    [PMID: 24900344]
    MOLT-4 IC50
    > 20 3
    Compound: AE
    Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay
    Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay
    [PMID: 24900344]
    OVCAR-3 IC50
    > 20 3
    Compound: AE
    Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay
    Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay
    [PMID: 24900344]
    Huh-7 CC50
    > 50 3
    Compound: 25
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    Cytotoxicity against human Huh7.5.1 cells by MTT assay
    [PMID: 22445328]
    MDA-MB-231 IC50
    12.24 3
    Compound: 1
    Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    SK-OV-3 IC50
    > 20 3
    Compound: AE
    Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay
    Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay
    [PMID: 24900344]
    MOLT-4 IC50
    >20 3
    Compound: AE
    Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay
    Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay
    [PMID: 24900344]
    Huh-7 EC50
    20.8 3
    Compound: 25
    Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
    Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay
    [PMID: 22445328]
    OVCAR-3 IC50
    >20 3
    Compound: AE
    Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay
    Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay
    [PMID: 24900344]
    SK-OV-3 IC50
    >20 3
    Compound: AE
    Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay
    Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay
    [PMID: 24900344]
    MCF7 IC50
    4.14 3
    Compound: 1
    Anticancer activity against human MCF-7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Anticancer activity against human MCF-7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    MCF7 IC50
    > 20 3
    Compound: AE
    Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay
    Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay
    [PMID: 24900344]
    MDA-MB-231 IC50
    12.24 3
    Compound: 1
    Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 34124677]
    MOLT-4 IC50
    > 20 3
    Compound: AE
    Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay
    Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay
    [PMID: 24900344]
    OVCAR-3 IC50
    > 20 3
    Compound: AE
    Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay
    Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay
    [PMID: 24900344]
    SK-OV-3 IC50
    > 20 3
    Compound: AE
    Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay
    Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay
    [PMID: 24900344]
    体外実験

    Aloe emodin (0-15 μM; 24-96 h) inhibits PC3 cell proliferation in a dose-dependent manner[1].
    Aloe emodin (0-15 μM; 24 h) inhibits the activation of mTORC2 downstream substrates, Akt and PKCα. Aloe emodin could bind with mTORC2 in cells and inhibit its kinase activity[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Viability Assay[1]

    Cell Line: PC3 cells
    Concentration: 0 μM, 2.5 μM, 5 μM, 10 μM or 15 μM
    Incubation Time: 24 h, 48 h, 72 h or 96 h
    Result: Suppressed proliferation and anchorage-independent growth of PC3 cells.

    Western Blot Analysis[1]

    Cell Line: PC3 cells
    Concentration: 0 μM, 2.5 μM, 5 μM, 10 μM or 15 μM
    Incubation Time: 24 h
    Result: Inhibited the activation of the downstream substrates of mTORC2, Akt and PKCα.
    体内実験

    Aloe emodin (10-50 mg/kg) suppresses tumor growth by inhibiting mTOR complex2 activity[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Athymic nude mice (BALB/c nude mouse, 6 weeks old)[1]
    Dosage: 10 mg/kg, 50 mg/kg (20% PEG400 in autoclaved PBS)
    Administration: Intraperitoneal injection, five times per week; for 28 days
    Result: Exhibited tumor suppression effects in vivo in an athymic nude mouse model.
    分子量

    270.24

    分子式

    C15H10O5

    CAS 番号
    Appearance

    Solid

    Color

    Brown to orange

    SMILES

    O=C1C2=C(C=CC=C2O)C(C3=CC(CO)=CC(O)=C13)=O

    Structure Classification
    Initial Source
    輸送条件

    Room temperature in continental US; may vary elsewhere.

    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : ≥ 20.83 mg/mL (77.08 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.7004 mL 18.5021 mL 37.0041 mL
    5 mM 0.7401 mL 3.7004 mL 7.4008 mL
    10 mM 0.3700 mL 1.8502 mL 3.7004 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始)

    C1

    ×
    体積 (開始)

    V1

    =
    濃度 (終了)

    C2

    ×
    体積 (終了)

    V2

    体内:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: 2.08 mg/mL (7.70 mM); Suspended solution; Need ultrasonic

      This protocol yields a suspended solution of 2.08 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: 2.08 mg/mL (7.70 mM); Suspended solution; Need ultrasonic

      This protocol yields a suspended solution of 2.08 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    純度とドキュメンテーション

    純度: 98.32%

    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 3.7004 mL 18.5021 mL 37.0041 mL 92.5104 mL
    5 mM 0.7401 mL 3.7004 mL 7.4008 mL 18.5021 mL
    10 mM 0.3700 mL 1.8502 mL 3.7004 mL 9.2510 mL
    15 mM 0.2467 mL 1.2335 mL 2.4669 mL 6.1674 mL
    20 mM 0.1850 mL 0.9251 mL 1.8502 mL 4.6255 mL
    25 mM 0.1480 mL 0.7401 mL 1.4802 mL 3.7004 mL
    30 mM 0.1233 mL 0.6167 mL 1.2335 mL 3.0837 mL
    40 mM 0.0925 mL 0.4626 mL 0.9251 mL 2.3128 mL
    50 mM 0.0740 mL 0.3700 mL 0.7401 mL 1.8502 mL
    60 mM 0.0617 mL 0.3084 mL 0.6167 mL 1.5418 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

     

    カスタマ需要量 *

    お名前 *

     

    タイトル

    メールアドレス *

     

    電話番号 *

    デパートメント

     

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

         

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    Aloe emodin
    製品番号:
    HY-N0189
    数量:
    MCE 日本正規代理店: